文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤术后立体定向放疗:手术通道是否需要作为靶区

Stereotactic Radiosurgery for Resected Brain Metastases: Does the Surgical Corridor Need to be Targeted?
PubMed 文献 · Pract Radiat Oncol · 2020-05-16

该回顾性研究纳入2007至2018年间64例患者共66个深部脑转移瘤(术前距软脑膜表面≥1.0 cm),比较术后立体定向放疗(SRS)是否包含手术通道作为靶区的肿瘤控制与毒性。

要点

  • 深部脑转移瘤术后SRS省略手术通道靶区未显著增加通道或瘤腔复发。
  • 省略通道可缩小SRS体积,可能允许剂量提升以改善瘤腔控制。

核心结论

  • 深部脑转移瘤术后SRS省略手术通道靶区未显著影响通道或瘤腔复发及不良反应,但软脑膜病变发生率更高。

研究设计与样本

  • 回顾性研究纳入2007至2018年间64例患者共66个深部脑转移瘤(术前距软脑膜表面≥1.0 cm),比较术后SRS是否包含手术通道靶区。

主要发现

  • 66个深部脑转移瘤中43个(65%)包含手术通道靶区。

临床怎么用

  • 对于深部脑转移瘤术后SRS,省略手术通道靶区未显著增加通道或瘤腔复发,但需关注软脑膜病变风险升高。
  • 省略通道可缩小SRS体积,可能为剂量提升创造条件以改善瘤腔控制。

局限性

  • 本研究为回顾性研究,样本量有限(64例患者66个病灶),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although consensus guidelines for postresection stereotactic radiosurgery (SRS) for brain metastases recommend the surgical corridor leading to the resection cavity be included in the SRS plan, no study has reported patterns of tumor recurrence based on inclusion or exclusion of the corridor as a target. We reviewed tumor control and toxicity outcomes of postresection SRS for deep brain metastases based on whether or not the surgical corridor was targeted. MATERIALS AND METHODS: We retrospectively reviewed patients who had resected brain metastases treated with SRS between 2007 and 2018 and included only "deep" tumors (defined as located ≥1.0 cm from the pial surface before resection). RESULTS: In 66 deep brain metastases in 64 patients, the surgical corridor was targeted in 43 (65%). There were no statistical differences in the cumulative incidences of progression at 12 months for targeting versus not targeting the corridor, respectively, for overall local failure 2% (95% confidence interval [CI], 0%-11%) versus 9% (95% CI, 1%-25%; P = .25), corridor failure 0% (95% CI, 0%-0%) versus 9% (95% CI, 1%-25%; P = .06), cavity failure 2% (95% CI, 0%-11%) versus 0% (95% CI, 0%-0%; P = .91), and adverse radiation effect 5% (95% CI, 1%-15%) versus 13% (95% CI, 3%-30%; P = .22). Leptomeningeal disease (7%; 95% CI, 2%-18%) versus 26% (95% CI, 10%-45%; P = .03) was higher in those without the corridor targeted. CONCLUSIONS: Omitting the surgical corridor in postoperative SRS for resected brain metastases was not associated with statistically significant differences in corridor or cavity recurrence or adverse radiation effect. As seen in recent prospective trials of postresection SRS, the dominant pattern of progression is within the resection cavity; omission of the corridor would yield a smaller SRS volume that could allow for dose escalation to potentially improve local cavity control.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Shi S, Sandhu N, Jin M, et al. Stereotactic Radiosurgery for Resected Brain Metastases: Does the Surgical Corridor Need to be Targeted? Pract Radiat Oncol. 2020. PMID: 32428766. doi:10.1016/j.prro.2020.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。